Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Stocks starts higher on an oil price rise and earnings beats

In the small cap world, the Russell 2,000, was around seven points higher at 1,146.

Stocks opened higher on Tuesday after a good day yesterday, as a recovery in the oil price and a slew of better-than-expected earnings reports helped to boost the major indices.

Brent rallied 3.1% to US$44.30 per barrel, while West Texas Intermediary futures climbed 3.2% to US$41.10 as the market shrugged off the Doha disappointments from the weekend.

The blue-chip index, the S&P 500, was up eight points at 2,102 after an hour of trading, while the Dow Jones climbed 70 points to 18,073.

Dow constituents Johnson & Johnson (NYSE:JNJ) and UnitedHealth Group Inc (NYSE:UNH) produced strong quarterly earnings reports, offsetting weaker reports from Goldman Sachs Group Inc (NYSE:GS) and International Business Machines Corp. (NYSE:IBM).

In the small cap world, the Russell 2,000, was around seven points higher at 1,146.

Of the movers, XG Technolgy Inc (NASDAQ:XGTI) was a big gainer after it received an order to supply its xMax software-defined cognitive radio (SDCR) networking equipment to the U.S. Army's Intelligence Electronic Warfare Test Directorate (IEWTD). Shares climbed 12.5% to US$0.09.

Elsewhere, Transgenomic Inc (NASDAQ:TBIO) leapt almost 17.5% to US$0.69 as it unveiled its new breast cancer analysis panel this week.

It wasn’t all good news however, as Rennova Health Inc (NASDAQ) dropped 7.8% to US$0.5 as it saw revenues more than halve to US$37.9mln in 2015 compared to the year before as it continued to be hit by “challenges faced by all rehab laboratories”.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK